S C Schachter
Overview
Explore the profile of S C Schachter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gersner R, Ekstein D, Dhamne S, Schachter S, Rotenberg A
Epilepsy Res
. 2015 Oct;
117:97-103.
PMID: 26432930
Huperzine A (HupA) is a naturally occurring compound found in the firmoss Huperzia serrata. While HupA is a potent acetylcholinesterase inhibitor, its full pharmacologic profile is incompletely described. Since previous...
2.
Peng Y, Lee D, Jiang L, Ma Z, Schachter S, Lemere C
Neuroscience
. 2007 Oct;
150(2):386-95.
PMID: 17945434
Alpha-secretase (alpha-secretase), cleaves the amyloid precursor protein (APP) within the amyloid-beta (Abeta) sequence, resulting in the release of a secreted fragment of APP (alphaAPPs) and precluding Abeta generation. We investigated...
3.
Schachter S
Expert Opin Investig Drugs
. 2005 Jul;
8(7):1103-12.
PMID: 15992110
Oxcarbazepine (OXC) was introduced in 1990 and is now registered in 54 countries worldwide as monotherapy, as add-on treatment for partial seizures, with or without secondarily generalised seizures, and primary...
4.
Schachter S
Expert Opin Investig Drugs
. 2005 Jul;
6(10):1327-35.
PMID: 15989504
Despite the recent introduction of new anti-epileptic drugs (AEDs), many patients with epilepsy, especially those with partial-onset seizures, continue to have seizures that are refractory to pharmacotherapy. Other patients are...
5.
French J, Kanner A, Bautista J, Abou-Khalil B, Browne T, Harden C, et al.
Neurology
. 2004 Apr;
62(8):1261-73.
PMID: 15111660
Objective: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and zonisamide) in the treatment of children and...
6.
French J, Kanner A, Bautista J, Abou-Khalil B, Browne T, Harden C, et al.
Neurology
. 2004 Apr;
62(8):1252-60.
PMID: 15111659
Objective: To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) (gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, and zonisamide-reviewed in the order in which these...
7.
Schachter S
Drugs Today (Barc)
. 2004 Apr;
34(3):283-9.
PMID: 15094857
Tiagabine inhibits gamma-aminobutyric acid uptake into neurons and glia. This mechanism of action is specific and unique among the antiepileptic drugs (AEDs). Tiagabine is efficacious in animal seizure models at...
8.
Vadlamudi L, Andermann E, Lombroso C, Schachter S, Milne R, Hopper J, et al.
Neurology
. 2004 Apr;
62(7):1127-33.
PMID: 15079012
Objective: To classify the Lennox twin pairs according to modern epilepsy classifications, use the classic twin model to identify which epilepsy syndromes have an inherited component, search for evidence of...
9.
Fisher R, Schachter S
Epilepsy Behav
. 2003 Mar;
1(1):52-9.
PMID: 12609127
Some of the disability deriving from epilepsy derives from the postictal state (PS). The PS may be complicated by impaired cognition, headache, injuries, or secondary medical conditions. Postictal depression is...
10.